These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 29860760)
1. [The influence of molecular classification of breast cancer on the safety of breast-conserving surgery]. Li Y; Mu L; Ruan YX; Wang YT; Zhang D; Zhou H; Wang X Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):341-346. PubMed ID: 29860760 [No Abstract] [Full Text] [Related]
2. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data]. Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034 [No Abstract] [Full Text] [Related]
3. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery]. Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761 [No Abstract] [Full Text] [Related]
4. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer]. Liu ZF; Chen C; Yao XL; Sun SR Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638 [TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy]. Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762 [No Abstract] [Full Text] [Related]
6. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes]. Zhang HM; Zhang BN; Xuan LX; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556 [TBL] [Abstract][Full Text] [Related]
8. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy? Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421 [TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
10. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study. Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy. Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867 [TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of different subtypes of breast cancer]. Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523 [TBL] [Abstract][Full Text] [Related]
13. Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age. Zhong Y; Xu Y; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Pan B; Wang C; Peng L; Huang X; Li Y; Wang X; Sun Q Breast Cancer Res Treat; 2020 Jul; 182(1):117-126. PubMed ID: 32430680 [TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognosis analysis of different breast cancer molecular subtypes]. Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer]. Wu SY; Tan Y; Guan YS Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945 [TBL] [Abstract][Full Text] [Related]
16. [Oncological safety and prognosis factors analysis of immediate breast reconstruction after nipple-areola-complex sparing mastectomy]. Li ZJ; Zhang P; Zhang W; Zhang Z; Wang XM; Xiao CH Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):690-695. PubMed ID: 30293396 [No Abstract] [Full Text] [Related]
17. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment. Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473 [TBL] [Abstract][Full Text] [Related]
18. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer. Choi YJ; Shin YD; Song YJ World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132 [TBL] [Abstract][Full Text] [Related]
19. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy]. Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805 [No Abstract] [Full Text] [Related]
20. Is conservative surgery a good option for patients with "triple negative" breast cancer? Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]